Omega-3 Fatty Acid DHA Proves More Useful In Treating Fatty Liver Disease – Study

A U.S. study in lab animals comparing two omega-3 fatty acids finds that onehad the greatest effect on nonalcoholic fatty liver disease. Researchers report that EPA did little to prevent the scarring (fibrosis) associated with nonalcoholic steatohepatitis (NASH). DHA supplementation, however, reduced the proteins involved in liver fibrosis by more than 65 percent. Liver inflammation and fibrosis are common problems growing steadily as the obesity problem worsens among Americans. "Based on these results, DHA may be a more attractive dietary supplement than EPA for the prevention and potential treatment of NASH in obese humans," researchers concluded.